Invention Grant
- Patent Title: Bioerodible drug delivery devices
-
Application No.: US16006395Application Date: 2018-06-12
-
Publication No.: US11298323B2Publication Date: 2022-04-12
- Inventor: Hong Guo , Jianbing Chen
- Applicant: EyePoint Pharmaceuticals, Inc.
- Applicant Address: US MA Watertown
- Assignee: EyePoint Pharmaceuticals, Inc.
- Current Assignee: EyePoint Pharmaceuticals, Inc.
- Current Assignee Address: US MA Watertown
- Agency: Medler Ferro Woodhouse & Mills PLLC
- Main IPC: A61K9/28
- IPC: A61K9/28 ; A61K9/20

Abstract:
This invention relates to a bioerodible drug delivery device that can be implanted in a patient at or near an area in need of treatment. The bioerodible drug delivery device can be used to deliver a wide variety of different pharmaceutically active agents, and can do so at a controlled rate and over an extended period of time. The bioerodible drug delivery device includes a bioerodible polymeric outer housing with one or more delivery ports for delivering the pharmaceutically active agent(s) contained therein. The polymer used as the bioerodible polymeric outer housing is not substantially degraded during the dosing of the pharmaceutically active agent(s) in the bioerodible drug delivery device. The invention also provides methods of making the bioerodible drug delivery device and using it for the treatment of diseases and disorders.
Public/Granted literature
- US20180353431A1 BIOERODIBLE DRUG DELIVERY DEVICES Public/Granted day:2018-12-13
Information query